Xoma Corp $4.24

up +0.06


22/8/2014 04:00 PM  |  NASDAQ : XOMA  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get XOMA Trend Analysis - it has underperformed the S&P 500 by 26%

Partner Headlines

  1. MLV & Co Has Positive Outlook On XOMA

    Benzinga
  2. Morning Market Movers

    Benzinga
  3. UPDATE: MLV & Co Upgrades XOMA on Valuation

    Benzinga
  4. XOMA Finalizes Plans for Gevokizumab Phase 3 Clinical Program in Pyoderma ...

    Benzinga
  5. Benzinga's Top Downgrades

    Benzinga
  6. UPDATE: MLV & Co Downgrades XOMA on Valuation/Sentiment

    Benzinga
  7. Mid-Afternoon Market Update: FuelCell Energy Hangs on to Gains as Canadian ...

    Benzinga
  8. Mid-Day Market Update: Smith & Wesson Surges On Upbeat Results; XOMA Shares ...

    Benzinga
  9. Mid-Morning Market Update: Markets Mostly Flat; Brown-Forman Posts Higher ...

    Benzinga
  10. Morning Lowers for Mar. 5, 2014: XOMA, USU, CSIQ, AUDC, RATE

    Benzinga
  11. Benzinga's Top #PreMarket Losers

    Benzinga
  12. UPDATE: XOMA Offers Update on Gevokizumaba, Says Results Do Not Support ...

    Benzinga
  13. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, XOMA, ...

    Benzinga
  14. Stocks Hitting 52-Week Highs

    Benzinga
  15. Benzinga's Top #PreMarket Losers

    Benzinga
  16. XOMA Announces Closing of the Offering and Exercise of 1.425M Share Over ...

    Benzinga
  17. XOMA Announces Pricing of 9.5M Shares at $5.25 per Share

    Benzinga
  18. XOMA Prices 9.5M Share Offering at $5.25/Share

    Benzinga
  19. Benzinga's Top #PreMarket Losers

    Benzinga
  20. Benzinga's Top #PreMarket Gainers

    Benzinga
  21. Xoma Shares Rise 6% After-Hours on Encouraging Phase 2 Gevokizumab Results

    Benzinga
  22. XOMA Shares Quiet Following Results of Two Phase 2 Trials Showing Gevokizumab ...

    Benzinga
  23. UPDATE: Piper Jaffray Initiates XOMA at Overweight on 'Xciting Antibody ...

    Benzinga
  24. Benzinga's Top Initiations

    Benzinga
  25. Benzinga's Top Pre-Market Losers

    Benzinga
  26. UPDATE: Wedbush Raises PT to $5 on Xoma on Gevokizumab Initial Efficacy

    Benzinga
  27. XOMA Says Sevier Initiated Proof-of-Concept Gevokizumab Study for Acute ...

    Benzinga
  28. XOMA Corp (XOMA) CFO & VP Finance Fred Kurland sells 9,111 Shares

    GuruFocus
  29. XOMA Announces Servier Has Initiated Phase 3 Gevokizumab Trial in Patients ...

    Benzinga
  30. UPDATE: XOMA Receives Orphan Drug Designation From FDA for Gevokizumab

    Benzinga
  31. XOMA Ltd. Reports Operating Results (10-Q)

    GuruFocus
  32. CMC Biologics Acquires XOMA's Bay Area Manufacturing Facility; Terms Not ...

    Benzinga
  33. Oncobiologics Announces Agreement To Utilize XOMA's Fully Human Antibody ...

    Benzinga
  34. Health Care Sector Wrap

    FoxBusiness
  35. Benzinga's Top Initiations

    Benzinga
  36. Earnings Scheduled For March 6

    Benzinga
  37. End-of-Day Market Summary for January 17, 2012

    Benzinga
  38. Xoma Shares Down After Job Cuts and One Time Charges Announced

    Benzinga
  39. Benzinga's Microcap Movers for Thursday January 5, 2012

    Benzinga
  40. XOMA Streamlines Operations to Invest in Value-Creating Activities; Cuts ...

    Benzinga
  41. XOMA Corporation New CEO Says Company Expects to Initiate Global Gevokizumab ...

    Benzinga
  42. XOMA Appoints John Varian as Chief Executive Officer

    Benzinga
  43. XOMA Will Move Its Corporate Domicile to Delaware

    Benzinga
  44. XOMA Initiates Gevokizumab Phase 2 Study for Moderate to Severe Acne Vulgaris

    Benzinga
Trading Center